The Annals New | Pharmaco Epidemiology and Therapeutic Risk Management
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 11 October 2005, www.theannals.com, DOI 10.1345/aph.1G165.
 The Annals of Pharmacotherapy: Vol. 39, No. 11, pp. 1911-1917. DOI 10.1345/aph.1G165
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benrimoj, S. I
Right arrow Articles by Roberts, A. S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benrimoj, S. I
Right arrow Articles by Roberts, A. S

Providing Patient Care in Community Pharmacies in Australia

Shalom I Benrimoj, PhD

Dean and Professor of Pharmacy Practice, Faculty of Pharmacy, University of Sydney, Sydney, Australia

Alison S Roberts, BPharm (Hons)

PhD Candidate, Faculty of Pharmacy, University of Sydney

Reprints: Dr. Benrimoj, Faculty of Pharmacy A15, University of Sydney, NSW 2006, Australia, fax 61 2 93514391, benrimojc{at}chs.usyd.edu.au

OBJECTIVE: To describe Australia's community pharmacy network in the context of the health system and outline the provision of services.

DATA SYNTHESIS: The 5000 community pharmacies form a key component of the healthcare system for Australians, for whom health expenditures represent 9% of the Gross Domestic Product. A typical community pharmacy dispenses 880 prescriptions per week. Pharmacists are key partners in the Government's National Medicines Policy and contribute to its objectives through the provision of cognitive pharmaceutical services (CPS). The Third Community Pharmacy Agreement included funding for CPS including medication review and the provision of written drug information. Funding is also provided for a quality assurance platform with which the majority of pharmacies are accredited. Fifteen million dollars (Australian) have been allocated to research in community pharmacy, which has focused on achieving quality use of medicines (QUM), as well as developing new CPS and facilitating change. Elements of the Agreements have taken into account QUM principles and are now significant drivers of practice change. Although accounting for 10% of remuneration for community pharmacy, the provision of CPS represents a significant shift in focus to view pharmacy as a service provider. Delivery of CPS through the community pharmacy network provides sustainability for primary health care due to improvement in quality presumably associated with a reduction in healthcare costs.

CONCLUSIONS: Australian pharmacy practice is moving strongly in the direction of CPS provision; however, change does not occur easily. The development of a change management strategy is underway to improve the uptake of professional and business opportunities in community pharmacy.

Key Words: Australia, cognitive pharmaceutical services, community pharmacy, education, research

Published Online, October 11, 2005. www.theannals.com, DOI 10.1345/aph.1G165


This article has been cited by other articles:


Home page
 The Annals of PharmacotherapyHome page
A. S Roberts, S. I Benrimoj, T. F Chen, K. A Williams, and P. Aslani
Practice Change in Community Pharmacy: Quantification of Facilitators
Ann. Pharmacother., June 1, 2008; 42(6): 861 - 868.
[Abstract] [Full Text] [PDF]


homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.